New Non-Destructive Inspection, Blister Recovery and Packaging Technologies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New Non-Destructive Inspection, Blister Recovery and Packaging Technologies launched by Sepha Ltd.

Three new products aimed at meeting the changing demands of global pharma-companies are being introduced by the pharmaceutical packaging equipment specialist, Sepha Ltd.

The first machine, BottleScan, is the world’s first tool-less, non-destructive leak detection instrument for testing multiple induction-sealed bottles simultaneously.  It incorporates force decay technology to test induction-sealed bottles for holes and weak seals without destroying the contents. Ahead of itsEuropean debut, BottleScan has already attracted orders from Asian and North American customers.

Press Out Universal Mini is a low volume, rapid product change over deblistering unit that enables product to be recovered from all blister pack types, particularlychild resistant,peel-able and senior-friendly packs. The unit has been developed to reflect changes in the pharmaceutical manufacturing market, where manufacturers are focusing on shorter runs of more bespoke, high value drugs in child resistant or senior-friendly blister packs.

Finally, EZ MedPakextends Sepha's 'EZ' range of low volume, package development unitsinto the wider medical packaging market. It is aimed specifically at medical device and packaging development teams who want to take control of their own pack designs and develop bespoke packs for small devices and pre-filled syringes.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here